GENE:LSE:LSE-UBS (Irl) ETF Public Limited Company - Global Gender Equality UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 1672.5

Change

+2.00 (+0.12)%

Market Cap

N/A

Volume

2.59K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-1.32 (-0.91%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.06 (+0.33%)

USD 581.04B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.14%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.15 (-0.24%)

USD 266.08B
0QZO:LSE 0QZO

+1.00 (+0.92%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.10 (+0.34%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

-0.57 (-0.33%)

USD 202.26B
0R24:LSE Intel Corp.

+0.19 (+0.89%)

USD 196.14B

ETFs Containing GENE:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.41% 68% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.41% 68% D+ 66% D+
Trailing 12 Months  
Capital Gain 16.91% 68% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.91% 66% D+ 67% D+
Trailing 5 Years  
Capital Gain 58.37% 73% C 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 58.37% 71% C- 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 19.48% 85% B 84% B
Dividend Return 19.48% 85% B 83% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 192.42% 12% F 10% F
Risk Adjusted Return 10.13% 29% F 42% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.